India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Storm Therapeutics raises $56M in Series C funding to accelerate cancer therapy development and expand its innovative ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Mayo Clinic Comprehensive Cancer Center scientists, physicians and trainees will present nearly 60 studies on emerging cancer therapies, diagnostics and prevention strategies at the 2026 American ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies.

Super-enhancers (SEs) are large clusters of transcriptional regulatory elements that drive oncogene expression, maintain malignancy, and create ...

Most gene-editing tools are blind to context. Point them at a DNA sequence and they cut, whether that sequence sits inside a ...

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a ...

Creative Biogene is proud to announce the launch of its innovative iPSC RNA reprogramming products, specifically designed to enhance the efficiency and safety of iPSC generation.

Why does the same genetic mutation cause a severe brain malformation in some patients but not in others? Researchers from the ...